A comparative analysis of positron emission tomography and mediastinoscopy in staging non–small cell lung cancer
- 31 December 2003
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 126 (6), 1900-1904
- https://doi.org/10.1016/s0022-5223(03)01036-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?The Annals of Thoracic Surgery, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Mediastinal Lymph Node Sampling Following Positron Emission Tomography With Fluorodeoxyglucose Imaging in Lung Cancer StagingChest, 2001
- Comparative Efficacy of Positron Emission Tomography With Fluorodeoxyglucose in Evaluation of Small (3 cm) Lymph Node LesionsChest, 2000
- The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinomaCancer, 1998
- Positron Emission Tomography in Lung CancerThe Annals of Thoracic Surgery, 1998
- Prospective investigation of positron emission tomography in lung nodules.Journal of Clinical Oncology, 1998
- Likelihood of Malignancy in a Solitary Pulmonary NoduleChest, 1997
- Revisions in the International System for Staging Lung CancerChest, 1997
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995